Related Experiment Videos
Striatal plasticity and extrapyramidal motor dysfunction
1Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, NIH, Building 10, Room 5C103, 90900 Rockville Pike, Bethesda, MD 20892, USA. chaset@ninds.nih.gov
Parkinsonism & Related Disorders
|June 16, 2004
Summary
Parkinson's disease causes motor dysfunction through altered striatal neuron signaling. Dopamine receptor overstimulation leads to changes in NMDA and AMPA receptors, impacting motor control.
Area of Science:
- Neuroscience
- Molecular Biology
- Neurology
Background:
- Parkinson's disease (PD) involves motor dysfunction.
- Striatal dopamine receptor stimulation is implicated in PD pathogenesis.
- Therapeutic regimens can lead to nonphysiologic stimulation.
Purpose of the Study:
- To elucidate molecular events underlying motor dysfunction in Parkinson's disease.
- To understand the role of striatal medium spiny neurons in PD.
- To identify mechanisms of motor response complications.
Main Methods:
- Studies in animal models of Parkinson's disease.
- Analysis of patient data.
- Investigation of signaling cascades in medium spiny neurons.
- Examination of ionotropic glutamatergic receptor phosphorylation.
Main Results:
- Nonphysiologic stimulation of dopamine receptors causes plastic changes in striatal medium spiny neurons.
- Aberrant signaling cascades modify ionotropic glutamatergic receptors.
- NMDA and AMPA receptor sensitization increases cortical excitatory input, compromising motor function.
Conclusions:
- Aberrant signaling in medium spiny neurons contributes to Parkinson's disease motor dysfunction.
- Receptor sensitization alters striatal output, affecting motor control.
- Findings offer insights into motor memory and synaptic integration, aiding new treatment development.